XML 37 R25.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidating Financial Information (Tables)
9 Months Ended
Dec. 31, 2016
Consolidating Financial Information [Abstract]  
Condensed Balance Sheet [Table Text Block]

 
Condensed Consolidating Balance Sheet
 
December 31, 2016
(in thousands)
Parent Company
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$
209,656

 
$
286,155

 
$

 
$
495,811

Accounts receivable, less allowance

 
52,724

 
368,376

 

 
421,100

Intercompany accounts and notes receivable

 
416,247

 
19,416

 
(435,663
)
 

Inventories

 
92,911

 
381,726

 
(70,020
)
 
404,617

Prepaid expenses

 
30,843

 
7,263

 

 
38,106

Other receivables

 
7,223

 
75,043

 

 
82,266

Other current assets

 
45,539

 
478

 

 
46,017

Total current assets

 
855,143

 
1,138,457

 
(505,683
)
 
1,487,917

Property and equipment, net

 
1,018,563

 
317,204

 

 
1,335,767

Goodwill

 
1,953,102

 
220,812

 

 
2,173,914

Intangible assets, net

 
650,052

 
884,046

 

 
1,534,098

Long-term investments

 
25,958

 
8,775

 

 
34,733

Long-term intercompany accounts and notes receivable

 
555,909

 
132,572

 
(688,481
)
 

Investment in subsidiaries
6,149,591

 
1,664,718

 

 
(7,814,309
)
 

Other non-current assets
888

 
34,172

 
23,422

 

 
58,482

Total assets
$
6,150,479

 
$
6,757,617

 
$
2,725,288

 
$
(9,008,473
)
 
$
6,624,911

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 

Current liabilities:
 
 
 
 
 
 
 
 

Accounts payable
$

 
$
129,372

 
$
158,055

 
$
526

 
$
287,953

Intercompany accounts and notes payable

 
19,416

 
416,247

 
(435,663
)
 

Accrued liabilities
5,931

 
89,705

 
41,363

 

 
136,999

Other current liabilities

 
1,271

 
122,373

 

 
123,644

Total current liabilities
5,931

 
239,764

 
738,038

 
(435,137
)
 
548,596

Long-term debt
988,886

 

 

 

 
988,886

Deferred tax liabilities
(120,164
)
 
218,067

 
41,350

 

 
139,253

Long-term intercompany accounts and notes payable
412,710

 
132,572

 
143,199

 
(688,481
)
 

Other long-term liabilities

 
35,393

 
49,667

 

 
85,060

Total liabilities
1,287,363

 
625,796

 
972,254

 
(1,123,618
)
 
1,761,795

Total stockholders’ equity
4,863,116

 
6,131,821

 
1,753,034

 
(7,884,855
)
 
4,863,116

Total liabilities and stockholders’ equity
$
6,150,479

 
$
6,757,617

 
$
2,725,288

 
$
(9,008,473
)
 
$
6,624,911


 
Condensed Consolidating Balance Sheet
 
April 2, 2016
(in thousands)
Parent Company
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$

 
$
220,633

 
$
205,248

 
$

 
$
425,881

Short-term investments

 
186,808

 

 

 
186,808

Accounts receivable, less allowance

 
203,488

 
112,868

 

 
316,356

Intercompany accounts and notes receivable

 
532,508

 
404,330

 
(936,838
)
 

Inventories

 
186,627

 
325,346

 
(84,422
)
 
427,551

Prepaid expenses

 
56,151

 
7,699

 

 
63,850

Other receivables

 
37,033

 
10,347

 

 
47,380

Other current assets

 
40,866

 
518

 

 
41,384

Total current assets

 
1,464,114

 
1,066,356

 
(1,021,260
)
 
1,509,210

Property and equipment, net

 
807,586

 
239,495

 
(193
)
 
1,046,888

Goodwill

 
1,868,816

 
266,881

 

 
2,135,697

Intangible assets, net

 
786,314

 
1,026,201

 

 
1,812,515

Long-term investments

 
26,050

 

 

 
26,050

Long-term intercompany accounts and notes receivable

 
564,397

 
267,823

 
(832,220
)
 

Investment in subsidiaries
6,151,119

 
1,645,846

 

 
(7,796,965
)
 

Other non-current assets
1,091

 
39,478

 
25,890

 

 
66,459

Total assets
$
6,152,210

 
$
7,202,601

 
$
2,892,646

 
$
(9,650,638
)
 
$
6,596,819

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 

Current liabilities:
 
 
 
 
 
 
 
 

Accounts payable
$

 
$
141,792

 
$
66,508

 
$
(2,936
)
 
$
205,364

Intercompany accounts and notes payable

 
404,330

 
532,508

 
(936,838
)
 

Accrued liabilities
25,445

 
93,609

 
18,835

 

 
137,889

Other current liabilities

 
20,122

 
10,426

 

 
30,548

Total current liabilities
25,445

 
659,853

 
628,277

 
(939,774
)
 
373,801

Long-term debt
988,130

 

 

 

 
988,130

Deferred tax liabilities
(93,340
)
 
195,462

 
50,038

 

 
152,160

Long-term intercompany accounts and notes payable
232,303

 
267,823

 
332,094

 
(832,220
)
 

Other long-term liabilities

 
39,288

 
43,768

 

 
83,056

Total liabilities
1,152,538

 
1,162,426

 
1,054,177

 
(1,771,994
)
 
1,597,147

Total stockholders’ equity
4,999,672

 
6,040,175

 
1,838,469

 
(7,878,644
)
 
4,999,672

Total liabilities and stockholders’ equity
$
6,152,210

 
$
7,202,601

 
$
2,892,646

 
$
(9,650,638
)
 
$
6,596,819


Condensed Statement of Comprehensive Income [Table Text Block]
 
Condensed Consolidating Statement of Operations and Comprehensive Income (Loss)
 
Three Months Ended December 31, 2016
(in thousands)
Parent Company
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
Revenue
$

 
$
280,380

 
$
803,114

 
$
(257,147
)
 
$
826,347

Cost of goods sold

 
227,543

 
800,529

 
(512,367
)
 
515,705

Gross profit

 
52,837

 
2,585

 
255,220

 
310,642

Operating expenses:
 
 
 
 
 
 
 
 

Research and development
9,115

 
1,972

 
106,749

 
(5,885
)
 
111,951

Selling, general and administrative
7,540

 
43,652

 
91,052

 
(11,572
)
 
130,672

Other operating expense

 
6,087

 
551

 

 
6,638

Total operating expenses
16,655

 
51,711

 
198,352

 
(17,457
)
 
249,261

Income (loss) from operations
(16,655
)
 
1,126

 
(195,767
)
 
272,677

 
61,381

Interest expense
(14,090
)
 
(594
)
 
(1,751
)
 
1,971

 
(14,464
)
Interest income

 
914

 
1,290

 
(1,971
)
 
233

Other (expense) income

 
530

 
(1,313
)
 
(1,826
)
 
(2,609
)
Income (loss) before income taxes
(30,745
)
 
1,976

 
(197,541
)
 
270,851

 
44,541

Income tax (expense) benefit
6,948

 
(5,949
)
 
(124,178
)
 

 
(123,179
)
Income in subsidiaries
(54,841
)
 

 

 
54,841

 

Net income (loss)
$
(78,638
)
 
$
(3,973
)
 
$
(321,719
)
 
$
325,692

 
$
(78,638
)
 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss)
$
(78,462
)
 
$
(4,001
)
 
$
(321,515
)
 
$
325,516

 
$
(78,462
)
 
Condensed Consolidating Statement of Operations and Comprehensive Income (Loss)
 
Three Months Ended January 2, 2016
(in thousands)
Parent Company
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
Revenue
$

 
$
361,796

 
$
780,824

 
$
(521,939
)
 
$
620,681

Cost of goods sold

 
343,516

 
567,436

 
(521,259
)
 
389,693

Gross profit

 
18,280

 
213,388

 
(680
)
 
230,988

Operating expenses:
 
 
 
 
 
 
 
 
 
Research and development
13,827

 
5,468

 
93,386

 
(6,689
)
 
105,992

Selling, general and administrative
16,481

 
27,815

 
90,819

 
(8,821
)
 
126,294

Other operating expense

 
11,762

 
(107
)
 
260

 
11,915

Total operating expenses
30,308

 
45,045

 
184,098

 
(15,250
)
 
244,201

Income (loss) from operations
(30,308
)
 
(26,765
)
 
29,290

 
14,570

 
(13,213
)
Interest expense
(7,276
)
 
(618
)
 
(894
)
 
1,120

 
(7,668
)
Interest income

 
688

 
788

 
(957
)
 
519

Other income (expense)

 
(178
)
 
(457
)
 
(4
)
 
(639
)
Income (loss) before income taxes
(37,584
)
 
(26,873
)
 
28,727

 
14,729

 
(21,001
)
Income tax (expense) benefit
9,811

 
462

 
(399
)
 

 
9,874

Income in subsidiaries
16,646

 

 

 
(16,646
)
 

Net income (loss)
$
(11,127
)
 
$
(26,411
)
 
$
28,328

 
$
(1,917
)
 
$
(11,127
)
 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss)
$
(11,199
)
 
$
(26,433
)
 
$
28,278

 
$
(1,845
)
 
$
(11,199
)
 
Condensed Consolidating Statement of Operations and Comprehensive Income (Loss)
 
Nine Months Ended December 31, 2016
(in thousands)
Parent Company
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
Revenue
$

 
$
957,423

 
$
2,377,752

 
$
(945,593
)
 
$
2,389,582

Cost of goods sold

 
812,947

 
1,808,869

 
(1,136,150
)
 
1,485,666

Gross profit

 
144,476

 
568,883

 
190,557

 
903,916

Operating expenses:
 
 
 
 
 
 
 
 
 
Research and development
27,032

 
24,239

 
320,280

 
(16,385
)
 
355,166

Selling, general and administrative
46,259

 
118,465

 
290,290

 
(42,164
)
 
412,850

Other operating expense

 
10,274

 
7,504

 
5,607

 
23,385

Total operating expenses
73,291

 
152,978

 
618,074

 
(52,942
)
 
791,401

Income (loss) from operations
(73,291
)
 
(8,502
)
 
(49,191
)
 
243,499

 
112,515

Interest expense
(44,025
)
 
(2,001
)
 
(5,070
)
 
5,891

 
(45,205
)
Interest income

 
3,906

 
2,481

 
(5,684
)
 
703

Other (expense) income

 
398

 
(478
)
 
(3,340
)
 
(3,420
)
Income (loss) before income taxes
(117,316
)
 
(6,199
)
 
(52,258
)
 
240,366

 
64,593

Income tax (expense) benefit
26,824

 
(56,493
)
 
(107,390
)
 

 
(137,059
)
Income in subsidiaries
18,026

 

 

 
(18,026
)
 

Net income (loss)
$
(72,466
)
 
$
(62,692
)
 
$
(159,648
)
 
$
222,340

 
$
(72,466
)
 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss)
$
(72,887
)
 
$
(62,647
)
 
$
(160,114
)
 
$
222,761

 
$
(72,887
)
 
Condensed Consolidating Statement of Operations and Comprehensive Income (Loss)
 
Nine Months Ended January 2, 2016
(in thousands)
Parent Company
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
Revenue
$

 
$
1,727,819

 
$
2,045,111

 
$
(1,770,273
)
 
$
2,002,657

Cost of goods sold

 
1,382,666

 
1,570,039

 
(1,745,401
)
 
1,207,304

Gross profit

 
345,153

 
475,072

 
(24,872
)
 
795,353

Operating expenses:
 
 
 
 
 
 
 
 
 
Research and development
52,102

 
98,100

 
213,339

 
(22,046
)
 
341,495

Selling, general and administrative
62,106

 
129,073

 
257,330

 
(41,493
)
 
407,016

Other operating expense

 
40,311

 
2,778

 
262

 
43,351

Total operating expenses
114,208

 
267,484

 
473,447

 
(63,277
)
 
791,862

Income (loss) from operations
(114,208
)
 
77,669

 
1,625

 
38,405

 
3,491

Interest expense
(7,855
)
 
(2,008
)
 
(2,049
)
 
3,036

 
(8,876
)
Interest income

 
1,835

 
2,100

 
(2,552
)
 
1,383

Other income (expense)

 
2,824

 
(861
)
 
1,898

 
3,861

Income (loss) before income taxes
(122,063
)
 
80,320

 
815

 
40,787

 
(141
)
Income tax (expense) benefit
35,460

 
(16,162
)
 
(23,800
)
 

 
(4,502
)
Income in subsidiaries
81,960

 

 

 
(81,960
)
 

Net income (loss)
$
(4,643
)
 
$
64,158

 
$
(22,985
)
 
$
(41,173
)
 
$
(4,643
)
 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss)
$
(5,872
)
 
$
62,885

 
$
(22,941
)
 
$
(39,944
)
 
$
(5,872
)

Condensed Cash Flow Statement [Table Text Block]
 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended December 31, 2016
(in thousands)
Parent Company
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
Net cash provided by operating activities
$
135,096

 
$
72,180

 
$
322,473

 
$

 
$
529,749

Investing activities:
 
 
 
 
 
 
 
 
 
Purchase of property and equipment

 
(275,018
)
 
(111,937
)
 

 
(386,955
)
Purchase of a business, net of cash acquired

 

 
(118,133
)
 

 
(118,133
)
Purchase of available-for-sale securities

 
(469
)
 

 

 
(469
)
Proceeds from maturities and sales of available-for-sale securities

 
186,793

 

 

 
186,793

Other investing activities

 
4,279

 
(8,900
)
 

 
(4,621
)
Net cash used in investing activities

 
(84,415
)
 
(238,970
)
 

 
(323,385
)
Financing activities:
 
 
 
 
 
 
 
 

Excess tax benefit from exercises of stock options
12

 

 

 

 
12

Proceeds from the issuance of common stock
38,417

 

 

 

 
38,417

Repurchase of common stock, including transaction costs
(158,491
)
 

 

 

 
(158,491
)
Tax withholding paid on behalf of employees for restricted stock units
(15,034
)
 

 

 

 
(15,034
)
Other financing activities

 
20

 

 

 
20

Net transactions with related parties

 
1,238

 
(1,238
)
 

 

Net cash (used in) provided by financing activities
(135,096
)
 
1,258

 
(1,238
)
 

 
(135,076
)
Effect of exchange rate changes on cash

 

 
(1,358
)
 

 
(1,358
)
Net increase (decrease) in cash and cash equivalents

 
(10,977
)
 
80,907

 

 
69,930

Cash and cash equivalents at the beginning of the period

 
220,633

 
205,248

 

 
425,881

Cash and cash equivalents at the end of the period
$

 
$
209,656

 
$
286,155

 
$

 
$
495,811

 
 
 
 
 
 
 
 
 
 

 
Condensed Consolidating Statement of Cash Flows
 
Nine Months Ended January 2, 2016
(in thousands)
Parent Company
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
Net cash provided by (used in) operating activities
$
(206,611
)
 
$
643,342

 
$
91,502

 
$

 
$
528,233

Investing activities:
 
 
 
 
 
 
 
 
 
Purchase of property and equipment

 
(196,067
)
 
(35,087
)
 

 
(231,154
)
Purchase of available-for-sale securities

 
(343,466
)
 

 

 
(343,466
)
Proceeds from maturities and sales of available-for-sale securities

 
391,522

 

 

 
391,522

Other investing activities

 
668

 

 

 
668

Net cash used in investing activities

 
(147,343
)
 
(35,087
)
 

 
(182,430
)
Financing activities:
 
 
 
 
 
 
 
 

Proceeds from debt issuances
1,125,000

 

 

 

 
1,125,000

Payment of debt
(125,000
)
 

 

 

 
(125,000
)
Debt issuance costs
(12,890
)
 

 

 

 
(12,890
)
Excess tax benefit from exercises of stock options
339

 

 

 

 
339

Proceeds from the issuance of common stock
40,474

 

 

 

 
40,474

Repurchase of common stock, including transaction costs
(800,009
)
 

 

 

 
(800,009
)
Tax withholding paid on behalf of employees for restricted stock units
(21,303
)
 

 

 

 
(21,303
)
Other financing activities

 
87

 

 

 
87

Net transactions with related parties

 
(1,054
)
 
1,054

 

 

Net cash provided by (used in) financing activities
206,611

 
(967
)
 
1,054

 

 
206,698

Effect of exchange rate changes on cash

 

 
(718
)
 

 
(718
)
Net increase in cash and cash equivalents

 
495,032

 
56,751

 

 
551,783

Cash and cash equivalents at the beginning of the period

 
154,332

 
145,482

 

 
299,814

Cash and cash equivalents at the end of the period
$

 
$
649,364

 
$
202,233

 
$

 
$
851,597